Search

Your search keyword '"BABUDIERI, S."' showing total 439 results

Search Constraints

Start Over You searched for: Author "BABUDIERI, S." Remove constraint Author: "BABUDIERI, S."
439 results on '"BABUDIERI, S."'

Search Results

1. Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

2. Infections in lung transplanted patients: A review

3. Epidemiological and molecular characterization of HBV and HCV infections in HIV-1-infected inmate population in Italy: a 2017–2019 multicenter cross-sectional study

4. Effect of sodium–glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial

7. Correlations Between Olfactory Psychophysical Scores and SARS-CoV-2 Viral Load in COVID-19 Patients

8. Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C

9. Resistance analysis and treatment outcomes in hepatitis C virus genotype 3-infected patients within the Italian network VIRONET-C

10. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels

11. Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial

12. Travel-Related Typhoid Fever: Narrative Review of the Scientific Literature

13. Infections in lung transplanted patients: A review

16. The current and future off-label uses of dalbavancin: a narrative review.

17. Real life experiences in HCV management in 2018

18. Possibilities and limitations of forensic psychiatry services: Legislation and organization in an international and national perspective

19. Chronic hepatitis B virus infection in Italy during the twenty-first century: an updated survey in 2019

20. High HIV-1 diversity in immigrants resident in Italy (2008–2017)

21. Undetectable HCV-RNA at treatment-week 8 results in high-sustained virological response in HCV G1 treatment-experienced patients with advanced liver disease: the International Italian/Spanish Boceprevir/Peginterferon/Ribavirin Name Patients Program

26. Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial (Journal of Translational Medicine, (2020), 18, 1, (405), 10.1186/s12967-020-02573-9)

27. Il sistema REMS nella realtà italiana: autori di reato, disturbi mentali e PDTA

28. Possibilità e limiti dei Servizi di Psichiatria Forense: legislazione e organizzazione in un’ottica internazionale e nazionale

29. Erratum: Characteristics of patients with hepatitis C virus-related chronic liver diseases just before the era of oral direct-acting antiviral therapy in Italy (European Journal of Gastroenterology and Hepatology (2018) 30 (676-681) DOI: 10.1097/MEG.0000000000001099)

30. Possibilities and limitations of forensic psychiatry services: Legislation and organization in an international and national perspective

32. Systemic inflammatory markers and psychophysical olfactory scores in coronavirus disease 2019 patients: is there any correlation?

33. Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy

34. Current and future challenges in HCV: insights from an Italian experts panel

35. Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

37. Genetic Determinants in a Critical Domain of NS5A Correlate with Hepatocellular Carcinoma in Cirrhotic Patients Infected with HCV Genotype 1b

38. Is oral antibiotic therapy as effective as intravenous treatment in bacterial osteomyelitis? A real-life experience.

39. Evolving treatment implementation among HIV- infected pregnant women and their partners: Results from a national surveillance study in Italy, 2001-2015

40. Analysis of resistance and phylogenetic clusters in HCV-2c infected patients within the Italian network Vironet C

41. VIRONET-C real life experience of resistance-guided retreatment in HCV infected patients who previously failed a NS5A inhibitor-containing regimen

43. Evolving treatment implementation among HIV- infected pregnant women and their partners: Results from a national surveillance study in Italy, 2001-2015

46. DECLINE OF PREVALENCE OF RESISTANCE ASSOCIATED SUBSTITUTIONS TO NS3 AND NS5A INHIBITORS AT DAA- FAILURE IN HEPATITIS C VIRUS IN ITALY OVER THE YEARS 2015 TO 2018

48. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels

49. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels

50. Boceprevir or telaprevir in hepatitis C virus chronic infection: The Italian real life experience

Catalog

Books, media, physical & digital resources